Phase 3 Depression and Anxiety Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with major depressive disorder (a form of clinical depression) according to recognised diagnostic standards.
• People who are already taking a stable, prescribed medication for major depressive disorder.
• People who are willing and able to commit to the full duration of the study, attend all required visits, give themselves injections of the study medication, store the study medication correctly, keep electronic and paper diaries as required, and complete questionnaires throughout the study.

Who may not be able to join:

• People who have ever been diagnosed with, or currently have, schizophrenia or another psychotic disorder, bipolar disorder, borderline personality disorder, or any eating disorder.
• People who have type 1 diabetes, or a history of a dangerous build-up of acids in the blood (ketoacidosis), or a history of a serious diabetes-related condition involving very high blood sugar levels or loss of consciousness.
• People who have had a moderate or severe problem with substance or alcohol use within the 180 days before the screening appointment.
• People who are currently at risk of suicide or are considered by the study team to be at significant risk of suicide.
• People who have taken part in another clinical study and received an active treatment (or where it is unknown whether they received an active treatment) within 90 days or 5 half-lives of the study drug — whichever period is longer — before screening (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.